from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2511/orn

LFCtreatmentdescriptionclass of inhibitor

1.074

Amikacinug/mL Amikacintranslation

0.106

Cap5-10ug/mL Capreomycintranslation

-0.041

Rox10-50 ug/mL Roxithromycintranslation

0.608

SM2-5 ug/mL Streptomycintranslation

-1.269

Tet5-10 ug/mL Tetracyclinetranslation

-1.418

Rif0.2-5ug/mL Rifampicintranscription

-0.401

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.969

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.797

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.142

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.943

Clofazimine10-13 ug/mL Clofaziminerespiration

0.896

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.305

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.978

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.887

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.044

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.224

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.447

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.414

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.012

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.297

KCN5-20 ug/mL Potassium cyaniderespiration

1.048

NaN30.2-2 mM Sodium aziderespiration

1.290

Nigericin50 uM Nigericinrespiration

-0.384

TRC10-150 ug/mL Triclosanrespiration

0.299

TRZ10-25 ug/mL Thioridazinerespiration

-1.033

Valinomycin0.5-10 uM Valinomycinrespiration

2.489

ZnSO42 mM ZnSO4respiration

0.677

menadione6-10 ug/mL Menadionerespiration

0.186

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.597

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.064

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.027

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.770

NRP_1Non-replicating persistence stage 1dosRassociated

0.801

Amp0.2mg/mL AmpicillincellWall

0.730

Cephalexin20-100 ug/mL CephalexincellWall

0.628

Cerulenin0.32-5 ug/mL CerulenincellWall

0.063

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.098

EMB10-20 ug/mL EthambutolcellWall

0.769

Eta12-40 ug/mL EthionamidecellWall

0.917

INH0.2-0.4 ug/mL IsoniazidcellWall

0.449

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.927

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.859

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.264

BZA0.12 mg/mL BenzamidearomaticAmides

-0.584

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.230

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.059

H2O24 mM hydrogen peroxideDNAdamaging

0.093

Levo10 ug/mL LevofloxacinDNAdamaging

-0.140

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.316

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.407

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.557

UVUV-irradiationDNAdamaging

-0.022

ARP41-4 ug/mL Antitubercular compound ARP4?

0.429

Antimycin12.5-50 ug/mL Antimycin A?

0.698

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.475

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.029

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.194

PA8240.2-2 ug/mL PA-824?

-1.181

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.168

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.764

Verapamil50 uM Verapamil?

0.020

mercaptoethanol2 mM 2-Mercaptoethanol?

0.766

methoxatin10-20 ug/mL Methoxatin?